Sodium Citrate Blood
- Product NDC
- 63323-505
- 11-digit product format
- 633230505
- Labeler code
- 63323
- Product ID
- 63323-505_c4751431-5792-4fad-a13d-887e2e402907
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Anticoagulant Sodium Citrate Solution
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- BN770923
- Marketing category
- NDA
- Marketing start
- 2014-09-29
- Marketing end
- 0000-00-00
- Substance
- TRISODIUM CITRATE DIHYDRATE
- Active strength
- 4 g/100mL
- Pharmacologic classes
- Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63323-505-74 | 63323050574 | 250 mL in 1 BAG (63323-505-74) | 250 ml | 2014-09-29 | 0000-00-00 | No | No | Current |